Organisation paid for research Program year 2021 Source: CMS Open Payments

David B Kudrow

Neither a doctor nor a teaching hospital

Research payments

$82,375

11 payments

Through program year 2021, David B Kudrow is reported as receiving $82,375 in research payments, across 11 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$24,764	2
2020	Research	$17,711	2
2019	Research	$39,900	7

Breakdown

Who paid Research payments · program years 2019–2021

Amgen Inc. $33,612 2 payments
Eli Lilly and Company $32,706 8 payments
Genentech, Inc. $16,058 1 payment

Studies the money was for Research payments · program years 2019–2021

Phase 2 Episodic Migraine Prophylaxis EMP $33,612 2 payments
A Phase 3B Multicenter, Single-Arm, Open-Label Safety Study of Ly2951742 -Galcanezumab- in Patients With Episodic Or Chronic Cluster Headache $30,185 3 payments
Phase II Study of Anti Tau in Prodromal to Mild Ad $16,058 1 payment
An Open Label, Long Term, Safety Study of Lasmiditan 100 MG and 200 MG in the Acute Treatment of Migraine Gladiator $2,369 3 payments
A Phase 4 Single Blind Study of Gastrointestinal Transit Time in Adult Patients With Migraine Before and After Initiation of A Mab CGRP Antagonist $102 1 payment
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the Conquer Study $50 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.